Reuters (12/31, Erman, O’Donnell) reported pharmaceutical companies raised US prices for 2021 amid the “effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs.” The companies planned “to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.”
The Wall Street Journal (1/1, Hopkins, Subscription Publication) reported that according to an Rx Savings Solutions analysis, companies raised their prices by an average of 3.3%.
Related Links:
— “Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk “Michael Erman, Carl O’Donnell, Reuters, December 31, 2020